[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575750":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":22,"locations":27,"responsibleParty":47,"collaborators":10,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":10,"maxAge":10,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"University of Pittsburgh","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"GEMIN5",null,[12],"Other: GEMIN5-Related Neurodevelopmental Disorder",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"GEMIN5-Related Neurodevelopmental Disorder","This is an observational study. The investigators will collect data from participants' medical records regarding neurodevelopmental outcomes (eg. cognitive, speech and language, motor skills, developmental skills, vision, hearing), Time to event (Acquistion and loss of developmental milestones), and, if available, data regarding MRIs (presence of cerebellar atrophy), survival, visiion, hearing, and biomarkers of disease.",[9],[19],{"name":20,"affiliation":5,"role":21},"Kate Kielty, MD","PRINCIPAL_INVESTIGATOR",[23],{"name":20,"role":24,"phone":25,"phoneExt":10,"email":26},"CONTACT","412-692-6350","CCNG@chp.edu",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Children's Hospital of Pittsburgh of UPMC","RECRUITING","Pittsburgh","Pennsylvania","15224","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-79.99589,40.44062,{"lat":40,"lon":39},[43,44],{"name":20,"role":24,"phone":25,"phoneExt":10,"email":26},{"name":45,"role":46,"phone":10,"phoneExt":10,"email":10},"Deepa Soundara Rajan, MD","SUB_INVESTIGATOR",{"type":21,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Kate Kielty","Principal Investigator","100575750","natural-history-study-of-gemin-5-related-neurodevelopmental-disorder-100575750",false,"NCT06776341","Natural History Study of GEMIN-5 Related Neurodevelopmental Disorder","Retrospective and Longitudinal Prospective Natural History Study of GEMIN5-Related Neurodevelopmental Disorder","Inclusion Criteria:\n\n* Individuals with molecularly confirmed GEMIN5 biallelic mutations, ages 0 years and above\n\nExclusion Criteria:\n\n* none","ALL",{"count":59,"type":60},500,"ESTIMATED","26 Years","OBSERVATIONAL","This study will include a comprehensive retrospective chart review and a longitudinal prospective observational natural history study to characterize the phenotypic spectrum of GEMIN5-Related Neurodevelopmental Disorder. We aim to define the trajectory of this ultra-rare disease, core clinical features, characteristics at disease onset and diagnosis, neurological symptomatology, and neuroimaging findings over time. In this study, biological specimens (serum) will also be collected in a biorepository for translational research purposes.",[65,66,67],"SMN Complex Proteins","GEMIN5 Protein, Human","Neurodevelopmental Disorders",[9,67],"2026-07-07",{"date":71,"type":72},"2026-07-09","ACTUAL",{"date":74,"type":72},"2025-07-07",{"date":76,"type":60},"2050-12",{"name":5,"class":6},1]